已收盘 03-27 16:00:00 美东时间
-0.180
-1.36%
今日重点评级关注:Piper Sandler:维持Allogene疗法"超配"评级,目标价从7美元升至8美元;B. Riley证券:维持Oncology Institute"买入"评级,目标价从6美元升至8美元
03-16 18:19
Top Wall Street analysts changed their outlook on these top names. For a comple...
03-13 19:45
In a report released today, Anthony Elian from J.P. Morgan maintained a Hold ra...
03-13 19:17
Keefe, Bruyette & Woods analyst Christopher McGratty upgrades Flagstar Bank (NYSE:FLG) from Market Perform to Outperform and raises the price target from $14 to $16.
03-13 18:41
HICKSVILLE, N.Y., March 10, 2026 /PRNewswire/ -- Flagstar Bank, N.A. (NYSE: FLG) (the "Bank") has been recognized by Crisil Coalition Greenwich as Best Bank for Customer Service for Middle M...
03-10 20:30
Both Long-Term and Short-Term Deposit Ratings Raised to Investment Grade HICKSVILLE, N.Y., March 3, 2026 /PRNewswire/ -- Flagstar Bank, N.A. (NYSE: FLG) (the "Bank") today announced that Fit...
03-04 05:23
今日重点评级关注:HC Wainwright & Co.:维持Helus Pharma"买入"评级,目标价从55美元升至95美元;HC Wainwright & Co.:维持Compass Pathways"买入"评级,目标价从40美元升至70美元
03-03 20:22
华盛资讯2月28日讯,Flagstar Financial公布2025财年年度业绩,公司年度营收20.62亿美元,同比下降19.2%,归母净利润亏损2.10亿美元,同比亏损缩窄81.8%。
02-28 12:21
今日重点评级关注:花旗:维持Telix Pharmaceuticals"买入"评级,目标价从22美元升至22.5美元;摩根士丹利:维持Vir Biotechnology"超配"评级,目标价从20美元升至24美元
02-25 11:03
DA Davidson analyst Peter Winter maintains Flagstar Bank (NYSE:FLG) with a Buy and maintains $16 price target.
02-25 00:10